Derkast®: a complex approach in the treatment of patients with BA and COPD during hospital care

General practitioner, Pulmonologist

Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) belong to the diseases of the respiratory system, the treatment of which, unfortunately, is not always possible without hospitalization.
As a rule, an urgent care to such patients is provided with a focus on eliminating bronchial spasm in hospitals, which is a life-threatening condition. At the same time it is well known that progressive inflammation is the cause for the deterioration of health condition of patient during disease recurrence. This calls for the need to search for drugs, which could ensure the reliable control of inflammation in BA and COPD exacerbation. What are the special aspects of treatment of such patients in hospitals?

4 August, 2017

Authors:

Oleksandra Mierkulova

Products:

Derkast®

Learn more

Allergist

Justification of respiratory cytoprotection in children’s bronchial asthma

The anesthesiologist and specialist on medical emergency conditions

The first data on international multicenter clinical study RheoSTAT-CP0698 on the efficacy and safety of Rheosorbilact® infusion in therapy of pneumonia

Cardiologist

Endothellitis as an important factor of Long Covid and ways of medical correction

General practitioner

Antiseptic solution for the prevention and treatment of injuries and inflammatory processes of the skin

Cardiologist

Safety and effectiveness of Rheosorbilact detoxification therapy in stage 1–3 CKD

Cardiologist

The characteristics of preventive and therapeutic effectiveness of new domestic anti-septic medicinal product Horosten

The epidemiological situation at the end of the second millennium is characterized by a shift of etiological structure of infectious diseases towards those caused by opportunistic potentially pathogenic microorganisms.